Origin and therapy for hypertriglyceridaemia in type 2 diabetes

Table 3 Recommended treatment targets for diabetic dyslipidaemia

		NCEP ATP III[31]	ADA[30]	NVDPA[128]	European Guidelines[33]
LDL-cholesterol (mmol/L)	Very high risk	< 1.8	< 1.8	< 2.0	< 1.8
	High risk	< 2.6	< 2.6	< 2.0	< 2.5
Triglycerides (mmol/L)			< 1.7	< 2.0	< 1.7
HDL-cholesterol (mmol/L)	Male		> 1.0	≥ 1.0	> 1.0
	Female		> 1.3	≥ 1.0	> 1.2
Non-HDL cholesterol (mmol/L)	Very high risk	< 2.6	< 2.6	< 2.5	< 2.6
	High risk	< 3.4	< 3.4	< 2.5	< 3.3
ApoB (g/L)	Very high risk		< 0.8		< 0.8
	High risk		< 0.9		< 1.0

NCEP ATP III: Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III); ADA: American diabetes association; NVDPA: National vascular disease prevention alliance of australia; LDL: Low density lipoprotein; HDL: High density lipoprotein.